Johnson & Johnson (BCBA:JNJ)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021
Market Capitalization	533,628,408	359,038,955	305,053,882	81,804,459	46,247,751	34,837,220
Market Cap Growth	35.73%	17.70%	272.91%	76.88%	32.75%	51.55%
Enterprise Value	576,508,353	374,927,212	310,236,252	81,441,000	46,356,603	35,423,881
Last Close Price	14900.00	11312.22	9874.81	3902.19	2229.77	1420.62
PE Ratio	19.83	24.83	10.73	25.74	21.57	28.16
PS Ratio	4.96	3.93	4.43	5.77	5.72	5.02
PB Ratio	5.73	4.89	5.49	6.01	6.08	6.55
P/TBV Ratio	-	-	-	203.64	-	-
P/FCF Ratio	-	17.60	20.68	26.88	22.79	20.52
P/OCF Ratio	-	14.39	16.56	21.79	19.24	17.60
EV/Sales Ratio	4.73	4.11	4.51	5.75	5.73	5.10
EV/EBITDA Ratio	14.07	12.18	12.39	16.13	16.00	15.32
EV/EBIT Ratio	18.80	16.14	16.08	20.73	20.94	20.79
EV/FCF Ratio	26.18	18.38	21.03	26.76	22.85	20.87
Debt / Equity Ratio	0.65	0.53	0.44	0.53	0.47	0.57
Debt / EBITDA Ratio	1.67	1.26	0.98	1.42	1.22	1.31
Debt / FCF Ratio	2.74	1.91	1.67	2.37	1.76	1.80
Asset Turnover	0.48	0.51	0.48	0.43	0.44	0.50
Inventory Turnover	2.24	2.29	2.43	2.38	2.37	3.10
Quick Ratio	0.68	0.78	0.82	0.65	1.04	0.91
Current Ratio	1.01	1.11	1.16	0.99	1.35	1.21
Return on Equity (ROE)	30.21%	20.06%	18.31%	21.71%	25.93%	23.97%
Return on Assets (ROA)	7.61%	8.13%	8.40%	7.51%	7.55%	7.62%
Return on Capital (ROIC)	11.76%	13.55%	13.76%	12.25%	12.93%	13.49%
Return on Capital Employed (ROCE)	16.40%	17.40%	19.70%	16.90%	15.80%	15.30%
Earnings Yield	5.04%	4.03%	9.32%	3.89%	4.64%	3.55%
FCF Yield	4.13%	5.68%	4.84%	3.72%	4.39%	4.87%
Dividend Yield	1.54%	44.62%	38.48%	20.20%	19.30%	23.56%
Payout Ratio	53.34%	84.05%	33.48%	65.11%	52.84%	71.23%
Buyback Yield / Dilution	1.32%	5.12%	3.89%	0.38%	-0.12%	0.51%
Total Shareholder Return	2.86%	49.74%	42.37%	20.58%	19.17%	24.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.